Id |
Subject |
Object |
Predicate |
Lexical cue |
T76 |
1-12 |
NNP |
denotes |
Tocilizumab |
T77 |
12-13 |
-COMMA- |
denotes |
, |
T78 |
14-16 |
DT |
denotes |
an |
T79 |
17-25 |
NN |
denotes |
anti-IL6 |
T80 |
25-26 |
-COMMA- |
denotes |
, |
T81 |
27-30 |
MD |
denotes |
can |
T82 |
31-37 |
VB |
denotes |
confer |
T83 |
38-45 |
NN |
denotes |
benefit |
T84 |
46-48 |
IN |
denotes |
in |
T85 |
49-57 |
NNS |
denotes |
patients |
T86 |
58-62 |
IN |
denotes |
with |
T87 |
63-71 |
NN |
denotes |
COVID-19 |
T88 |
72-75 |
CC |
denotes |
and |
T89 |
76-80 |
JJ |
denotes |
high |
T90 |
81-84 |
NN |
denotes |
IL6 |
T91 |
87-95 |
NN |
denotes |
Abstract |
T92 |
96-99 |
DT |
denotes |
The |
T93 |
100-105 |
JJ |
denotes |
novel |
T94 |
106-117 |
NN |
denotes |
coronavirus |
T95 |
117-118 |
-COMMA- |
denotes |
, |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R73 |
T82 |
T80 |
arg1Of |
confer,"," |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
R75 |
T82 |
T81 |
arg2Of |
confer,can |
R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
R78 |
T82 |
T84 |
arg1Of |
confer,in |
R79 |
T85 |
T84 |
arg2Of |
patients,in |
R80 |
T85 |
T86 |
arg1Of |
patients,with |
R81 |
T88 |
T86 |
arg2Of |
and,with |
R82 |
T87 |
T88 |
arg1Of |
COVID-19,and |
R83 |
T90 |
T88 |
arg2Of |
IL6,and |
R84 |
T90 |
T89 |
arg1Of |
IL6,high |
R85 |
T94 |
T92 |
arg1Of |
coronavirus,The |
R86 |
T94 |
T93 |
arg1Of |
coronavirus,novel |
R87 |
T94 |
T95 |
arg1Of |
coronavirus,"," |